Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Other-Appropriated-Reserves" stands at 488.94 Billion Japanese Yens as of 06/30/2025.
As of the end of Astellas Pharma Inc.'s first quarter, the item "Other Appropriated Reserves" stands at 488.94 Billion JPY. This represents a decrease of -6.26 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -156.67 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -156.67 Billion Japanese Yens.
The 3 year change is 133.53 Billion Japanese Yens.
The 5 year change is 373.90 Billion Japanese Yens.
The 10 year change is 242.94 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Appropriated Reserves | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Appropriated Reserves | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Appropriated Reserves | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Appropriated Reserves | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Appropriated Reserves | 280,205,508,085.11 |